TEZSPIRE 210 mg/1.9mL
tezepelumab-ekko · INJECTION, SOLUTION · Amgen Inc
No Recall History
Plain English
TEZSPIRE is a injection, solution containing tezepelumab-ekko at 210 mg/1.9mL, taken subcutaneous. Manufactured by Amgen Inc.
Key Facts
- Brand Name
- TEZSPIRE
- Generic Name
- tezepelumab-ekko
- NDC Code (Product)
55513-112- Manufacturer
- Amgen Inc
- Strength
- 210 mg/1.9mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761224
- Drug Class
- Thymic Stromal Lymphopoietin Blocker [EPC]
- Marketing Start
- 12/17/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is TEZSPIRE used for?
TEZSPIRE contains tezepelumab-ekko. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is TEZSPIRE a controlled substance?
TEZSPIRE is not classified as a controlled substance by the DEA.
What is the generic name for TEZSPIRE?
The generic name for TEZSPIRE is tezepelumab-ekko. There are no other listed brand versions of tezepelumab-ekko.
What is the NDC code for TEZSPIRE 210 mg/1.9mL?
The NDC (National Drug Code) for TEZSPIRE 210 mg/1.9mL is 55513-112, listed by Amgen Inc.
Other TEZSPIRE Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)